Further studies on a large scale should be performed, and they might support the idea that ATF3 is useful as either a biomarker or therapeutic target of breast cancer, since breast cancer has been recognized as a heterogeneous disease (16). The gene discussed is ATF3; the disease is breast carcinoma.